Cargando…
Lettuce‐produced hepatitis C virus E1E2 heterodimer triggers immune responses in mice and antibody production after oral vaccination
The hepatitis C virus (HCV) is a major etiologic agent for severe liver diseases (e.g. cirrhosis, fibrosis and hepatocellular carcinoma). Approximately 140 million people have chronic HCV infections and about 500 000 die yearly from HCV‐related liver pathologies. To date, there is no licensed vaccin...
Autores principales: | Clarke, Jihong Liu, Paruch, Lisa, Dobrica, Mihaela‐Olivia, Caras, Iuliana, Tucureanu, Catalin, Onu, Adrian, Ciulean, Sonya, Stavaru, Crina, Eerde, Andre, Wang, Yanliang, Steen, Hege, Haugslien, Sissel, Petrareanu, Catalina, Lazar, Catalin, Popescu, Costin‐Ioan, Bock, Ralph, Dubuisson, Jean, Branza‐Nichita, Norica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698045/ https://www.ncbi.nlm.nih.gov/pubmed/28419665 http://dx.doi.org/10.1111/pbi.12743 |
Ejemplares similares
-
Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus‐neutralizing activity in vaccinated mice
por: Dobrica, Mihaela‐Olivia, et al.
Publicado: (2021) -
The “humanized” N‐glycosylation pathway in CRISPR/Cas9‐edited Nicotiana benthamiana significantly enhances the immunogenicity of a S/preS1 Hepatitis B Virus antigen and the virus‐neutralizing antibody response in vaccinated mice
por: Pantazica, Ana‐Maria, et al.
Publicado: (2023) -
Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS1(16-42) antigen
por: Pantazica, Ana-Maria, et al.
Publicado: (2022) -
N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis
por: Dobrica, Mihaela-Olivia, et al.
Publicado: (2020) -
Generation of a DSF-Guided Refolded Bacterially Expressed Hemagglutinin Ectodomain of Influenza Virus A/Puerto Rico/8/1934 H1N1 as a Model for Influenza Vaccine Antigens
por: Tofan, Vlad-Constantin, et al.
Publicado: (2023)